No relation between angiotensin-converting enzyme (ACE) inhibitor-induced cough and ACE gene polymorphism, plasma bradykinin, substance P and ACE inhibitor concentration in Japanese patients

Yakugaku Zasshi

Volumn 121, Issue 3, 2001, Pages 253-257

  Okumura, H ^a   Nishimura, E ^a   Kariya, S ^a   Ohtani, M ^a   Uchino, K ^a   Fukatsu, T ^a   Odanaka, J ^a   Takahashi, T ^a   Watanabe, K ^a   Itoh, T ^a   Hashiguchi, M ^a   Echizen, H ^a   Rikihisa, T ^a  

^a Tokyo Postal Services Agency Hospital   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Bradykinin; Cough; Genetic polymorphism; Substance P; Trandolapril

Indexed keywords

ALACEPRIL; BRADYKININ; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; SUBSTANCE P; TRANDOLAPRIL; TRANDOLAPRILAT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; COUGHING; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; NEPHRITIS;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BRADYKININ; CHRONIC DISEASE; COUGH; FEMALE; HUMANS; HYPERTENSION; INDOLES; MALE; MIDDLE AGED; NEPHRITIS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SUBSTANCE P;

EID: 0035079520     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.121.253     Document Type: Article

References (12)